ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022

NEXT STORY
Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment
PREV STORY
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September

author_avatar
NASDAQ Market News

Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates

author_avatar
NASDAQ Market News

Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020

author_avatar
NASDAQ Market News